Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college students
2040 EORTC item Q168: the psychometric performance of a single-item indicator of side-effect burden for people with cancer Tamara Jones 1 , Florian Zeman 2 , Michael Koller 2 , Andreia Moura 3 , Claire Piccinin 3 , Sandra Nolte 1 1 Person-Centred Research, Eastern Health Clinical School, Monash University, Melbourne, Australia, 2 Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2040 Aims Following the release of the US Food and Drug Administration (FDA) Guidance on core patient-reported outcomes in cancer clinical trials, there has been growing interest in using single items to measure treatment tolerability from the patients perspective
Interesting to see how much the field is shifting toward exposure sustainability and adherence realism rather than just mechanism complexity
More is not always better with MOTS-c
US$ 21.56
US$ 27.00
US$ 25.89
US$ 22.04
US$ 27.58
US$ 22.39
US$ 26.88
